- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02633748
Mindfulness Intervention to Improve Symptomology Among Cancer Survivors; Focus on Sleep and Stress Improvement
October 7, 2016 updated by: Prisma Health-Upstate
Mindfulness has been shown to help stress, fatigue, sleep complaints, and other symptoms but has not been extensively studied in cancer survivors.
This study will enroll cancer survivors at the Greenville Health System Cancer Institute Center for Integrative Oncology and Survivorship to undergo the Mindfulness Based Cancer Survivorship (MBCS) four-week program, with assessments before, immediately after, and three months after the intervention.
Results of the study will be used to develop new care models that improve cancer survivor stress and symptoms using mindfulness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Cancer survivors suffer with stress, fatigue, sleep complaints, pain, and many other adverse health effects.
Chronic stress is detrimental to quality of life and, potentially, length of survival among cancer survivors.
Mindfulness-Based Cancer Survivorship (MBCS) is a four-week standardized mindfulness program, adapted for cancer survivors from Mindfulness-Based Stress Reduction (MBSR).
MBCS teaches formal mindfulness practice (meditation) and informal mindfulness during daily activities.
Mindfulness has been shown to help stress, fatigue, sleep complaints, and other symptoms but has not been extensively studied in cancer survivors.
This study will enroll cancer survivors at the Greenville Health System Cancer Institute Center for Integrative Oncology and Survivorship to undergo the MBCS four-week mindfulness program, with assessments before, immediately after, and three months after the intervention.
The assessments will include 1) questionnaires to measure lifestyle, stress, meditation habits, and sleep impairment, 2) blood tests to measure various biomarkers (e.g., inflammatory cytokines), 3) using a BodyMedia's Sensewear® armband for a week to measure sleep and physical activity, and 4) salivary cortisol levels.
The forty participants will be randomized to either the intervention arm, the four-week MBCS mindfulness program, or the control arm, a brief control/breathing course.
After the three month post assessment, participants in the control arm will have the opportunity to take the MBCS course.
Results of the study will be used to develop new care models that improve cancer survivor stress and symptoms using mindfulness.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Greenville, South Carolina, United States, 29605
- Greenville Health System Cancer Institute Center for Integrative Oncology and Survivorship
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must be a cancer survivor
- Ability to read, write, and understand English
- Ability to participate in a group
Exclusion Criteria:
- Previous experience in a MBCS course
- Corticosteroid therapy greater than prednisone 25 mg per day or equivalent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intervention
The twenty participants in the intervention arm will undergo a pre-assessment, post assessment, and a three month follow-up assessment.
The pre and post assessments will ask participants to 1) fill out questionnaires to measure lifestyle, stress, meditations habits, and sleep impairment, 2) take a blood sample, 3) use a BodyMedia's Sensewear® armband for a week, and 4) provide salivary cortisol levels.
The three month follow-up will repeat everything done if the first two assessments, excluding the blood sample.
The intervention arm will also attend the weekly two and a half hour Mindfulness-Based Cancer Survivorship (MBSC) four-week program between the pre and post assessments.
|
Mindfulness-Based Cancer Survivorship (MBCS) is a four-week standardized mindfulness program, adapted for cancer survivors from Mindfulness-Based Stress Reduction (MBSR).
MBCS teaches formal mindfulness practice (meditation) and informal mindfulness during daily activities.
Mindfulness has been shown to help stress, fatigue, sleep complaints, and other symptoms but has not been extensively studied in cancer survivors.
Other Names:
|
No Intervention: Control
The twenty participants in the control arm will undergo the same pre assessment as the intervention arm, receive a presentation on breathing exercises, and undergo the same post and three-month follow-up assessments.
The control arm will also be offered the same Mindfulness-Based Cancer Survivorship program given to the intervention arm following the three month follow-up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical activity as measured by a Body Sensewear actigraph wore by the participants for a week pre-intervention, post intervention, and at a three month follow-up
Time Frame: 5 months
|
All 40 participants will wear a BodyMedia's Sensewear® armband for a week at three different points in the study.
The actigraphs collect data on physical activity by measuring, calories burned, minutes of vigorous activity, and hours of sleep.
Data such as height and weight are collected before administering armband to measure data accurately.
The data will be analyzed using SenseWear Pro 8.1 software and SAS v9.4.
|
5 months
|
Change in stress level measured by cortisol levels collected from self-administering saliva collection kits
Time Frame: 5 months
|
Participants will collect six serial saliva samples pre-invention, post-intervention, and at the 3-month follow-up.
The first four samples will be taken within the first hour of waking (first upon awakening, 15, 30, and 45 minutes after waking).
Participants will collect the last two samples one hour before dinner and one right before they go to bed.
All saliva samples will then be shipped to the University of Georgia for cortisol characterization.
|
5 months
|
Change in inflammation measured by analyzing blood samples collected pre and post intervention using inflammation markers
Time Frame: 5 months
|
Approximately 5ml of blood will be collected from each participant at the pre and post assessment.
The samples will be collected in a yellow top serum separator tube (SST).
Immediately following the blood draw, samples will be inverted gently 5 times and then stored upright to allow for clotting for a minimum of 30 minutes.
For processing, after balancing the centerfigure, the samples will be spun at 3,000 rpm for 15 minutes at 4⁰C.
After spinning, 1 ml of serum will be transferred into a cryovials using a clean pipet.
All cryovials will be stored at -80 in a freezer.
All samples will then be transported to School of Medicine, University of South Carolina where they will be analyzed using inflammation markers.
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in diet measured by the National Cancer Institute's fat and fruit and vegetables screeners
Time Frame: 5 months
|
The NCI questionnaire will be administered at pre-intervention, post-intervention (5 weeks later), and at a 3 month follow-up succeeding the post-intervention data collection.
The data collected from pre-intervention to the three-month follow up will take place in a 5 month timespan.
|
5 months
|
Change in sleep quality measured using the Pittsburgh Sleep Quality Index
Time Frame: 5 months
|
The Pittsburgh Sleep Quality Index questionnaire will be administered at pre-intervention, post-intervention (5 weeks later), and at a 3 month follow-up succeeding the post-intervention data collection.
The data collected from pre-intervention to the three-month follow up will take place in a 5 month timespan.
|
5 months
|
Change in level of stress measured by the Center for Epidemiologic Studies Depression Scale [CES-D 10]
Time Frame: 5 months
|
The CES-D 10 will be administered at pre-intervention, post-intervention (5 weeks later), and at a 3 month follow-up succeeding the post-intervention data collection.
The data collected from pre-intervention to the three-month follow up will take place in a 5 month timespan.
|
5 months
|
Change in level of stress measured by the Perceived Stress Scale (PSS)
Time Frame: 5 months
|
The PSS questionnaire will be administered at pre-intervention, post-intervention (5 weeks later), and at a 3 month follow-up succeeding the post-intervention data collection.
The data collected from pre-intervention to the three-month follow up will take place in a 5 month timespan.
|
5 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in meditation habits and awareness measured by the Mindful Attention Awareness Scale (MASS)
Time Frame: 5 months
|
The MASS questionnaire will be administered at pre-intervention, post-intervention (5 weeks later), and at a 3 month follow-up succeeding the post-intervention data collection.
The data collected from pre-intervention to the three-month follow up will take place in a 5 month timespan.
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mark O'Rourke, M.D., Prisma Health-Upstate
- Principal Investigator: Sara Robb, PhD, University of Georgia
- Principal Investigator: Michael Wirth, PhD, University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
November 19, 2015
First Submitted That Met QC Criteria
December 14, 2015
First Posted (Estimate)
December 17, 2015
Study Record Updates
Last Update Posted (Estimate)
October 10, 2016
Last Update Submitted That Met QC Criteria
October 7, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- Pro00047213
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Sequelae
-
Duke UniversityRecruitingAmputation; Postoperative, SequelaeUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceTerminated
-
University of Sao Paulo General HospitalCompletedSequelae | Amputation of Lower Limb Above KneeBrazil
-
Rennes University HospitalCompleted
-
Defense and Veterans Center for Integrative Pain...CompletedPain, Ketamine Infusion, Psychologic SequelaeUnited States
-
TC Erciyes UniversityCompletedSequelae of Fracture of Forearm and Upper ArmTurkey
-
Bitlis Eren UniversityCompletedSequelae of; Complications Surgical and Medical CareTurkey
-
Universidade do Vale do ParaíbaUnknownFatigue | Stroke SequelaeBrazil
-
Coordinación de Investigación en Salud, MexicoRecruitingStroke SequelaeMexico
Clinical Trials on Mindfulness-Based Cancer Survivorship
-
Emory UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Masonic Cancer Center, University of MinnesotaCompletedBreast Cancer | Colorectal Cancer | Ovarian Cancer | Uterine CancerUnited States
-
University of CalgaryRecruitingBreast Cancer | Colorectal Cancer | Chemotherapy EffectCanada
-
University Hospital, GenevaCompletedGynecologic CancerSwitzerland
-
Columbia UniversitySusan G. Komen Breast Cancer FoundationCompleted
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Albert Einstein College of Medicine; Icahn School... and other collaboratorsActive, not recruiting
-
Linda E. CarlsonAlberta Health services; University of Calgary; Princess Margaret Hospital, Canada and other collaboratorsActive, not recruiting
-
Weill Medical College of Cornell UniversityAvon FoundationCompletedBreast CancerUnited States
-
Weill Medical College of Cornell UniversityAvon FoundationCompletedGynecologic Cancer | Breast CancersUnited States
-
Indiana UniversityNational Cancer Institute (NCI); Walther Cancer InstituteCompleted